Detalhe da pesquisa
1.
KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancer.
Future Oncol
; 18(18): 2301-2309, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35378995
2.
Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward.
Medicina (Kaunas)
; 58(5)2022 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35630016
3.
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.
Breast Cancer Res Treat
; 163(3): 587-594, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28353061
4.
SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debate.
Future Oncol
; 18(11): 1301-1302, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35109688
5.
Explainable 3D CNN based on baseline breast DCE-MRI to give an early prediction of pathological complete response to neoadjuvant chemotherapy.
Comput Biol Med
; 172: 108132, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38508058
6.
Treatment-related adverse events of first-line immunotherapy versus sorafenib for advanced hepatocellular carcinoma: a meta-analysis.
Expert Opin Drug Saf
; 22(4): 323-329, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36426773
7.
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis.
Immunotherapy
; 15(2): 117-126, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36695110
8.
Prognostic power assessment of clinical parameters to predict neoadjuvant response therapy in HER2-positive breast cancer patients: A machine learning approach.
Cancer Med
; 12(22): 20663-20669, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37905688
9.
Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?
Expert Rev Gastroenterol Hepatol
; 16(4): 333-339, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35403533
10.
Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-Analysis.
J Clin Med
; 11(4)2022 Feb 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35207311
11.
Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY.
Expert Rev Gastroenterol Hepatol
; 16(3): 273-278, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35220866
12.
Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future.
Curr Oncol
; 29(2): 551-564, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35200550
13.
The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis.
J Pers Med
; 12(5)2022 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35629263
14.
Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 14(6)2022 Mar 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35326555
15.
Advances in novel systemic therapies for advanced hepatocellular carcinoma.
Future Med Chem
; 14(20): 1455-1470, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35997677
16.
Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress.
Curr Oncol
; 29(10): 7925-7931, 2022 10 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36290903
17.
An Invasive Disease Event-Free Survival Analysis to Investigate Ki67 Role with Respect to Breast Cancer Patients' Age: A Retrospective Cohort Study.
Cancers (Basel)
; 14(9)2022 Apr 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35565344
18.
Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer.
Expert Opin Investig Drugs
; 31(7): 707-713, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35575038
19.
Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis.
Cells
; 11(12)2022 06 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35740985
20.
Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI.
J Pers Med
; 11(4)2021 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33915842